Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

por Cabrera-Serrano, Antonio José, Sánchez-Maldonado, José Manuel, ter Horst, Rob, Macauda, Angelica, García-Martín, Paloma, Benavente, Yolanda, Landi, Stefano, Clay-Gilmour, Alyssa, Niazi, Yasmeen, Espinet, Blanca, Rodríguez-Sevilla, Juan José, Pérez, Eva María, Maffei, Rossana, Blanco, Gonzalo, Giaccherini, Matteo, Cerhan, James R., Marasca, Roberto, López-Nevot, Miguel Ángel, Chen-Liang, Tzu, Thomsen, Hauke, Gámez, Irene, Campa, Daniele, Moreno, Víctor, de Sanjosé, Silvia, Marcos-Gragera, Rafael, García-Álvarez, María, Dierssen-Sotos, Trinidad, Jerez, Andrés, Butrym, Aleksandra, Norman, Aaron D., Luppi, Mario, Slager, Susan L., Hemminki, Kari, Li, Yang, Berndt, Sonja I., Casabonne, Delphine, Alcoceba, Miguel, Puiggros, Anna, Netea, Mihai G., Försti, Asta, Canzian, Federico, Sainz, Juan
Publicado 2023

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

por García-Martín, Paloma, Díez, Ana Moñiz, Maldonado, José Manuel Sánchez, Serrano, Antonio José Cabrera, ter Horst, Rob, Benavente, Yolanda, Landi, Stefano, Macauda, Angelica, Clay-Gilmour, Alyssa, Hernández-Mohedo, Francisca, Niazi, Yasmeen, González-Sierra, Pedro, Espinet, Blanca, Rodríguez-Sevilla, Juan José, Maffei, Rossana, Blanco, Gonzalo, Giaccherini, Matteo, Puiggros, Anna, Cerhan, James, Marasca, Roberto, Cañadas-Garre, Marisa, López-Nevot, Miguel Ángel, Chen-Liang, Tzu, Thomsen, Hauke, Gámez, Irene, Moreno, Víctor, Marcos-Gragera, Rafael, García-Álvarez, María, Llorca, Javier, Jerez, Andrés, Berndt, Sonja, Butrym, Aleksandra, Norman, Aaron D., Casabonne, Delphine, Luppi, Mario, Slager, Susan L., Hemminki, Kari, Li, Yang, Alcoceba, Miguel, Campa, Daniele, Canzian, Federico, de Sanjosé, Silvia, Försti, Asta, Netea, Mihai G., Jurado, Manuel, Sainz, Juan
Publicado 2022